Influenza, Human  >>  Rapivab (peramivir)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rapivab (peramivir) / BioCryst
NCT00297050: Safety and Dose Study of Peramivir for Influenza Treatment

Completed
1
100
US
Peramivir
National Institute of Allergy and Infectious Diseases (NIAID)
Influenza
11/06
11/06

Download Options